Puma Biotechnology First Quarter 2026 Earnings Call May 7, 2026 ALISCATM-Lung1 (PUMA-ALI-4201) Interim Analysis May 7, 2026 2 Alisertib (MLN 8237) Orally Bioavailable Aurora Kinase A Drug Class: Benzazepine (AURKA) inhibitor 3 • Single-agent and combinational clinical activity in solid tumors including hormone receptor-positive breast cancer (HR+ MBC), triple negative breast cancer (TNBC), small cell lung cancer (SCLC), and head and neck cancer • Single-agent clinical activity in hematologic malignancies in ...